Sputnik V vaccine for COVID-19, developed by Russia’s Gamaleya National Research Institute of Epidemiology and Microbiology, has arrived in India.
The vaccine candidate arrived in the country following the nod to Hyderabad-based pharmaceutical company, Dr. Reddy’s Laboratories to conduct an adaptive phase 2/3 human clinical trial for the vaccine in India.
A video of small containers having the logo of Dr. Reddy’s and Sputnik V being unloaded from a vehicle went viral on social media on Wednesday.
The arrival of vaccine doses means that the trials for the vaccine would soon begin.
The phase 2 and 3 trials are to be conducted in India to understand the safety and efficacy of the virus.
Russia registered Sputnik V for public use in August, the first country to do so, though the approval came before the start of the large-scale trial in September.